About this episode

Dr. Margarita Fedorova discusses the DRAIN trial and the efficacy of acetazolamide in idiopathic normal pressure hydrocephalus.

Dr. Margarita Fedorova discusses the DRAIN trial and the efficacy of acetazolamide in idiopathic normal pressure hydrocephalus. Show citation: Virhammar J, Fasth O, Ekblom M, et al. Safety, tolerability, and efficacy of acetazolamide in idiopathic normal pressure hydrocephalus (DRAIN) in Sweden: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol . 2026;25(6):550-559. doi: 10.1016/S1474-4422(26)00126-2

More episodes of Neurology Minute

• Lab Minute: Human Prion Disease · July 21, 2026 · 4 min
• Lab Minute: Human Prion Disease · July 21, 2026 · 4 min
• July 2026 President Spotlight: Mid-Year Update · July 20, 2026 · 4 min
• Preparing ALS Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants · July 17, 2026 · 3 min
• When Drug Marketing Masquerades as Clinical Trials · July 16, 2026 · 3 min
• Diagnosis and Management of Headache · July 14, 2026 · 3 min

Explore listener stats, chart rankings, contacts and more on the Neurology Minute podcast page.